GRCE
Grace Therapeutics Inc.
$3.58
+$0.25(+7.51%)
83
Overall
--
Value
83
Tech
--
Quality
Market Cap
$44.68M
Volume
759.95K
52W Range
$1.75 - $5.18
Target Price
$8.97
Order:
Income Statement
| Metric | Trend | Chart | 2020 Mar | 2021 Mar | 2022 Mar | 2023 Mar | 2024 Mar | 2025 Mar |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | -- | $196.0K | -- | -- | -- | -- | ||
| Total Revenue | -- | $196.0K | -- | -- | -- | -- | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | -- | $76.0K | -- | -- | -- | -- | ||
| GROSS PROFIT | ||||||||
| Gross Profit | -- | $120.0K | -- | -- | -- | -- | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $24.4M | $10.8M | $15.3M | $18.2M | $12.9M | $16.7M | ||
| Research & Development | $16.0M | $4.2M | $5.6M | $10.0M | $4.7M | $9.5M | ||
| Research Expense | $16.0M | $4.2M | $5.6M | $10.0M | $4.7M | $9.5M | ||
| Selling, General & Administrative | $8.5M | $6.7M | $9.8M | $8.3M | $6.7M | $7.2M | ||
| Selling & Marketing Expenses | $2.7M | $1.1M | $518.0K | $661.0K | $252.0K | -- | ||
| General & Administrative Expenses | $5.8M | $5.5M | $9.3M | $7.6M | $6.4M | $7.2M | ||
| Salaries & Wages | $2.7M | $2.1M | -- | -- | -- | -- | ||
| Depreciation & Amortization | -- | $8.0K | -- | -- | -- | -- | ||
| Depreciation & Amortization | -- | $8.0K | -- | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | -- | $1.5M | -- | ||
| OPERATING INCOME | ||||||||
| Operating income | $-24.4M | $-10.7M | $-15.3M | $-18.2M | $-12.9M | $-16.7M | ||
| EBITDA | $-22.1M | $-19.0M | $-15.3M | $-51.8M | $-14.7M | $-12.8M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $1.1M | -- | -- | -- | -- | -- | ||
| Intinc | $336.0K | $-107.0K | $224.0K | $246.0K | $911.0K | $711.0K | ||
| Net Non-Operating Interest Income/Expense | $-1.1M | $-107.0K | $224.0K | $246.0K | $911.0K | $711.0K | ||
| Gain on Sale of Securities | $-1.1M | $-3.1M | -- | -- | -- | -- | ||
| Other Income/Expense | $-1.1M | $2.7M | $-4.9M | $-34.0M | $2.7M | $-3.2M | ||
| Other Special Charges | -- | -- | $147.0K | -- | -- | -- | ||
| SPECIAL ITEMS | ||||||||
| Special Income Charges | -- | $-5.7M | $-249.0K | -- | -- | -- | ||
| Impairment of Capital Assets | -- | $5.7M | $249.0K | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-24.4M | $-19.9M | $-9.9M | $-52.0M | $-14.7M | $-12.8M | ||
| Pre-Tax Income | $-25.5M | $-19.9M | $-9.9M | $-52.0M | $-14.7M | $-12.8M | ||
| INCOME TAX | ||||||||
| Tax Provision | -- | -- | $-648.0K | $-9.5M | $-1.8M | $-3.2M | ||
| NET INCOME | ||||||||
| Net Income | $-25.5M | $-19.9M | $-9.2M | $-42.4M | $-12.9M | $-9.6M | ||
| Net Income (Continuing Operations) | $-25.5M | $-19.9M | $-9.2M | $-42.4M | $-12.9M | $-9.6M | ||
| Net Income (Discontinued Operations) | $-25.5M | $-19.9M | $-9.2M | $-42.4M | $-12.9M | $-9.6M | ||
| Net Income (Common Stockholders) | $-25.5M | $-19.9M | $-9.2M | $-42.4M | $-12.9M | $-9.6M | ||
| Normalized Income | $-18.8M | $-8.7M | $-10.3M | $-27.6M | $-16.5M | $-16.0M | ||
| TOTALS | ||||||||
| Total Expenses | $-24.4M | $-10.9M | $15.3M | -- | -- | $16.7M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $10.6M | $1.9B | $36.8M | $44.6M | $9.5M | $12.1M | ||
| Average Shares Outstanding (Diluted) | $10.6M | $1.9B | $36.8M | $44.6M | $9.5M | $12.1M | ||
| Shares Outstanding | $13.8M | $13.8M | $13.8M | $13.8M | $13.8M | $13.7M | ||
| Basic EPS | $-2.4 | $-10.6K | $-0.27 | $-0.95 | $-1.35 | $-0.79 | ||
| Basic EPS (Continuing Operations) | $-2.4 | $-10.6K | $-0.27 | $-0.95 | $-1.35 | $-0.79 | ||
| Diluted EPS | $-2.4 | $-10.6K | $-0.27 | $-0.95 | $-1.35 | $-0.79 | ||
| Diluted EPS (Continuing Operations) | $-2.4 | $-10.6K | $-0.27 | $-0.95 | $-1.35 | $-0.79 | ||
| OTHER METRICS | ||||||||
| Other Gand A | $5.8M | $5.5M | $9.3M | $7.6M | $6.4M | $7.2M | ||
| Other Impairment Of Capital Assets | -- | -- | $249.0K | $33.9M | -- | -- | ||
| Other Write Off | -- | $264.0K | -- | -- | -- | -- | ||
| Write Off | -- | $413.0K | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GRCE | $3.58 | +7.5% | 759.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |